GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jenkem Technology Co 688356.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

76.32

+1.26%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jenkem Technology Co

Its shares trade on Shanghai under the ticker 688356.SS. It has been listed since 26 August 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥316.1m and net income of CN¥63.4m. At that date it held total assets of CN¥1.42bn and shareholders' equity of CN¥1.32bn.

Jenkem Technology Co., Ltd. engages in the research, development, production and sales of medical polyethylene glycol (PEG) and its active derivatives. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-08-26. The firm's primary products are medical polyethylene glycol and its active derivatives, which are used in research, development and production of drugs and medial devices, scientific research institutions and other fields. The firm is also involved in providing technical services, including patent and non-patent technology licensing services, as well as research and development services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
26 Aug 2020
Employees
252
Website
jenkem.com ↗

Leadership

Pay as last reported

  • Mr. Xuan ZhaoChairman of the Board, General Manager, since 2016CN¥1.4m
  • Ms. Lei HanChief Financial Officer, Director, since 2022CN¥626,500
  • Ms. Lihong GuoDeputy General Manager, Director, since 2016CN¥1.8m
  • Ms. Rujun ZhangDeputy General Manager, Director, since 2016CN¥684,100
  • Mr. Bin ChenSecretary of the BoardCN¥514,000
  • Mr. Gang LiDirector
  • Mr. Yuhe ZhaoDirectorCN¥120,000
  • Mr. Ke BiIndependent DirectorCN¥120,000
  • Mr. Chunfei WangIndependent DirectorCN¥120,000
  • Ms. Jie ZhangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Jenkem Technology Co Ltd employs 252 full-time staff members in Beijing.
  • The company produces medical polyethylene glycol for drug development.
  • Jenkem Technology offers patent licensing services to scientific institutions.

Weaknesses

  • The firm has only 252 employees compared to larger peers.
  • Jenkem Technology relies heavily on medical polyethylene glycol sales.
  • The company went public in August 2020 recently.

Opportunities

  • Jenkem Technology can expand its active derivatives product line.
  • The firm may license its non-patent technology services globally.
  • Growing demand for medical devices supports polyethylene glycol sales.

Threats

  • Competition in the pharmaceuticals sector affects Jenkem Technology.
  • Regulatory changes impact medical polyethylene glycol production standards.
  • Economic shifts influence scientific research institution funding levels.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.